Standout Papers
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance) (2014)
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline (2016)
- Challenges and opportunities in cancer immunotherapy: a Society for Immunotherapy of Cancer (SITC) strategic vision (2024)
Immediate Impact
2 by Nobel laureates 8 from Science/Nature 67 standout
Citing Papers
Breast cancer
2021 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Works of Deborah Collyar being referenced
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
2014 Standout
American Society of Clinical Oncology Technology Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and Raloxifene
1999
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Deborah Collyar | 1699 | 1661 | 297 | 669 | 69 | 3.1k | |
| Katharine Yao | 1717 | 1290 | 213 | 880 | 112 | 3.3k | |
| Melissa E. Hughes | 1933 | 2154 | 162 | 394 | 98 | 3.4k | |
| K Holli | 1306 | 1750 | 175 | 754 | 47 | 3.0k | |
| Ismail Jatoi | 1833 | 2276 | 498 | 1092 | 137 | 4.3k | |
| Simon Cawthorn | 1267 | 1673 | 246 | 1458 | 54 | 3.5k | |
| Margaret Kemeny | 900 | 1383 | 295 | 330 | 72 | 2.8k | |
| Daniel Rayson | 840 | 1941 | 372 | 313 | 136 | 3.3k | |
| Abenaa M. Brewster | 1463 | 2119 | 245 | 694 | 114 | 3.7k | |
| Jeffrey S. Abrams | 1649 | 2200 | 618 | 1238 | 103 | 4.3k | |
| Marco Rosselli Del Turco | 1451 | 2440 | 251 | 543 | 103 | 3.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...